Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Long-Term Investments (2016 - 2024)

Healthstream (HSTM) has disclosed Long-Term Investments for 14 consecutive years, with $4.0 million as the latest value for Q3 2024.

  • On a quarterly basis, Long-Term Investments fell 4.87% to $4.0 million in Q3 2024 year-over-year; TTM through Sep 2024 was $4.0 million, a 4.87% decrease, with the full-year FY2023 number at $4.1 million, down 8.5% from a year prior.
  • Long-Term Investments was $4.0 million for Q3 2024 at Healthstream, down from $4.1 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $8.5 million in Q2 2021 to a low of $4.0 million in Q3 2024.
  • A 5-year average of $5.6 million and a median of $4.6 million in 2022 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 79.97% in 2021, then plummeted 44.3% in 2022.
  • Healthstream's Long-Term Investments stood at $6.8 million in 2020, then rose by 2.89% to $7.0 million in 2021, then tumbled by 35.85% to $4.5 million in 2022, then dropped by 8.5% to $4.1 million in 2023, then dropped by 3.63% to $4.0 million in 2024.
  • Per Business Quant, the three most recent readings for HSTM's Long-Term Investments are $4.0 million (Q3 2024), $4.1 million (Q2 2024), and $4.1 million (Q1 2024).